Legal & General Group PLC Liva Nova PLC Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Liva Nova PLC stock. As of the latest transaction made, Legal & General Group PLC holds 115,071 shares of LIVN stock, worth $5.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115,071
Previous 115,071 -0.0%
Holding current value
$5.48 Million
Previous $6.04 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$43.38 - $54.59 $29,411 - $37,012
678 Added 0.59%
115,071 $6.04 Million
Q2 2024

Aug 14, 2024
SELL
$51.76 - $64.15 $343,479 - $425,699
-6,636 Reduced 5.48%
114,393 $6.27 Million
Q1 2024

May 14, 2024
SELL
$48.6 - $57.12 $493,533 - $580,053
-10,155 Reduced 7.74%
121,029 $6.77 Million
Q4 2023

Feb 15, 2024
SELL
$43.45 - $53.66 $8,516 - $10,517
-196 Reduced 0.15%
131,184 $6.79 Million
Q3 2023

Nov 14, 2023
SELL
$50.12 - $58.87 $42,251 - $49,627
-843 Reduced 0.64%
131,380 $6.95 Million
Q2 2023

Aug 14, 2023
SELL
$42.28 - $51.43 $69,254 - $84,242
-1,638 Reduced 1.22%
132,223 $6.8 Million
Q1 2023

May 15, 2023
BUY
$40.84 - $58.14 $210,285 - $299,362
5,149 Added 4.0%
133,861 $5.83 Million
Q4 2022

Feb 14, 2023
BUY
$43.88 - $56.16 $4,431 - $5,672
101 Added 0.08%
128,712 $7.15 Million
Q3 2022

Nov 14, 2022
SELL
$48.37 - $66.5 $165,667 - $227,762
-3,425 Reduced 2.59%
128,611 $6.53 Million
Q2 2022

Aug 22, 2022
BUY
$57.25 - $86.63 $125,205 - $189,459
2,187 Added 1.68%
132,036 $8.25 Million
Q1 2022

May 16, 2022
SELL
$71.02 - $86.99 $11,576 - $14,179
-163 Reduced 0.13%
129,849 $10.6 Million
Q4 2021

Feb 14, 2022
BUY
$76.72 - $92.68 $174,998 - $211,403
2,281 Added 1.79%
130,012 $11.4 Million
Q3 2021

Nov 15, 2021
BUY
$76.02 - $88.62 $1.25 Million - $1.46 Million
16,486 Added 14.82%
127,731 $10.1 Million
Q2 2021

Aug 12, 2021
SELL
$73.44 - $87.01 $905,294 - $1.07 Million
-12,327 Reduced 9.98%
111,245 $9.36 Million
Q1 2021

May 17, 2021
BUY
$62.9 - $82.41 $323,557 - $423,917
5,144 Added 4.34%
123,572 $9.11 Million
Q4 2020

Feb 12, 2021
SELL
$46.01 - $68.74 $8.15 Million - $12.2 Million
-177,216 Reduced 59.94%
118,428 $7.84 Million
Q3 2020

Nov 13, 2020
BUY
$41.91 - $57.81 $7.41 Million - $10.2 Million
176,771 Added 148.71%
295,644 $13.4 Million
Q2 2020

Aug 14, 2020
BUY
$39.87 - $56.9 $44,813 - $63,955
1,124 Added 0.95%
118,873 $5.72 Million
Q1 2020

May 14, 2020
SELL
$34.22 - $76.49 $111,420 - $249,051
-3,256 Reduced 2.69%
117,749 $5.33 Million
Q4 2019

Feb 13, 2020
BUY
$68.92 - $85.27 $493,191 - $610,192
7,156 Added 6.29%
121,005 $9.13 Million
Q3 2019

Nov 13, 2019
BUY
$71.74 - $86.35 $468,175 - $563,520
6,526 Added 6.08%
113,849 $8.4 Million
Q2 2019

Aug 14, 2019
BUY
$66.45 - $97.36 $3.35 Million - $4.91 Million
50,402 Added 88.55%
107,323 $7.72 Million
Q1 2019

May 15, 2019
BUY
$86.15 - $100.49 $285,673 - $333,224
3,316 Added 6.19%
56,921 $5.54 Million
Q4 2018

Feb 15, 2019
BUY
$84.14 - $125.42 $204,628 - $305,021
2,432 Added 4.75%
53,605 $4.9 Million
Q3 2018

Nov 20, 2018
BUY
$101.02 - $130.95 $354,883 - $460,027
3,513 Added 7.37%
51,173 $6.34 Million
Q2 2018

Aug 10, 2018
BUY
$81.75 - $105.37 $126,630 - $163,218
1,549 Added 3.36%
47,660 $4.76 Million
Q1 2018

May 17, 2018
BUY
$79.95 - $89.74 $442,683 - $496,890
5,537 Added 13.65%
46,111 $4.08 Million
Q4 2017

Feb 13, 2018
BUY
$71.8 - $88.21 $2.91 Million - $3.58 Million
40,574
40,574 $3.24 Million

Others Institutions Holding LIVN

# of Institutions
261
Shares Held
52.9M
Call Options Held
316K
Put Options Held
127K
View Full List

About LivaNova PLC

LIVN Quotes by TradingView
  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.55B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email